NO20070705L - Virituell kolonoskopi med rontgenmerkede fosfolipid eter analoger - Google Patents

Virituell kolonoskopi med rontgenmerkede fosfolipid eter analoger

Info

Publication number
NO20070705L
NO20070705L NO20070705A NO20070705A NO20070705L NO 20070705 L NO20070705 L NO 20070705L NO 20070705 A NO20070705 A NO 20070705A NO 20070705 A NO20070705 A NO 20070705A NO 20070705 L NO20070705 L NO 20070705L
Authority
NO
Norway
Prior art keywords
phospholipid ether
methods
colonoscopy
viral
ray
Prior art date
Application number
NO20070705A
Other languages
English (en)
Norwegian (no)
Inventor
Jamey P Weichert
Mark A Longino
Original Assignee
Cellectar Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cellectar Llc filed Critical Cellectar Llc
Publication of NO20070705L publication Critical patent/NO20070705L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0404—Lipids, e.g. triglycerides; Polycationic carriers
    • A61K51/0408—Phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/50—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications
    • A61B6/508—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications for non-human patients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/02—Arrangements for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
    • A61B6/03—Computed tomography [CT]
    • A61B6/037—Emission tomography

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Dentistry (AREA)
  • Pathology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
NO20070705A 2004-07-08 2007-02-07 Virituell kolonoskopi med rontgenmerkede fosfolipid eter analoger NO20070705L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52183104P 2004-07-08 2004-07-08
PCT/US2005/024259 WO2006014589A2 (en) 2004-07-08 2005-07-08 Virtual colonoscopy with radiolabeled phospholipid ether analogs

Publications (1)

Publication Number Publication Date
NO20070705L true NO20070705L (no) 2007-04-02

Family

ID=35503411

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20070705A NO20070705L (no) 2004-07-08 2007-02-07 Virituell kolonoskopi med rontgenmerkede fosfolipid eter analoger

Country Status (14)

Country Link
US (1) US7700075B2 (pt)
EP (1) EP1773408A2 (pt)
JP (1) JP2008508909A (pt)
KR (1) KR20070054630A (pt)
CN (1) CN101001647A (pt)
AU (1) AU2005269861A1 (pt)
BR (1) BRPI0511445A (pt)
CA (1) CA2572398A1 (pt)
IL (1) IL180363A0 (pt)
MX (1) MX2007000207A (pt)
NO (1) NO20070705L (pt)
NZ (1) NZ552914A (pt)
WO (1) WO2006014589A2 (pt)
ZA (1) ZA200700015B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8540968B2 (en) * 2004-03-02 2013-09-24 Cellectar, Inc. Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof
MXPA06009681A (es) * 2004-03-02 2007-03-15 Cellectar Llc Analogos de fosfolipido para el diagnostico y tratamiento del cancer.
KR20080005178A (ko) * 2004-12-20 2008-01-10 셀렉타, 엘엘씨 암 검출 및 치료용 인지질 에테르 동족체
WO2006114658A2 (en) * 2005-04-28 2006-11-02 Yeda Research And Development Co., Ltd Lung cancer diagnosis using magnetic resonance imaging data obtained at three time points
US7414254B2 (en) * 2005-06-28 2008-08-19 United Pharmacy Partners, Inc. Tungsten pig for radio-pharmaceuticals
US20070208331A1 (en) * 2006-03-02 2007-09-06 Chu Michael S Systems and methods of treatment within a gastrointestinal lumen
EP1985713A1 (en) * 2007-04-05 2008-10-29 Vereniging voor christelijk hoger onderwijs, wetenschappelijk onderzoek en patiëntenzorg Methods and tools for detecting the presence of colorectal adenocarcinoma cells
US20080319315A1 (en) * 2007-06-07 2008-12-25 Beth Israel Deaconess Medical Center Method of reducing interferences in positron emission tomography
WO2010011844A1 (en) * 2008-07-25 2010-01-28 Tufts Medical Center A system and method of clinical treatment planning of complex, monte carlo-based brachytherapy dose distributions
EP2429591B1 (en) 2009-05-11 2015-08-26 Cellectar, Inc. Fluorescent phospholipid ether compounds, compositions, and methods of use
US8871181B2 (en) 2009-05-11 2014-10-28 Cellectar, Inc. Fluorescent phospholipid ether compounds, compositions, and methods of use
WO2010144788A2 (en) * 2009-06-12 2010-12-16 Cellectar, Inc. Ether and alkyl phospholipid compounds for treating cancer and imaging and detection of cancer stem cells
JP2013504590A (ja) * 2009-09-11 2013-02-07 セレクター，インコーポレイティド 非放射性リン脂質化合物、組成物、及び使用方法
EA201890869A3 (ru) 2010-06-03 2019-03-29 Фармасайкликс, Инк. Применение ингибиторов тирозинкиназы брутона (btk)
KR101341288B1 (ko) 2013-10-24 2013-12-12 사회복지법인 삼성생명공익재단 방사선 치료기의 품질 보증 시스템 및 그 품질 보증 방법
WO2015143400A1 (en) 2014-03-20 2015-09-24 Pharmacyclics, Inc. Phospholipase c gamma 2 and resistance associated mutations
DK3750545T3 (da) 2014-11-17 2024-04-22 Cellectar Biosciences Inc Phospholipidetheranaloger som cancermålrettede lægemiddelbærere
JP6841609B2 (ja) 2015-07-10 2021-03-10 ３スキャン インコーポレイテッド 組織学的染色の空間的多重化
AU2017300361A1 (en) * 2016-07-18 2019-02-07 Wisconsin Alumni Research Foundation Radiohalogenated agents for In Situ Immune Modulated Cancer Vaccination
RU2755010C1 (ru) * 2021-01-26 2021-09-09 Федеральное государственное бюджетное научное учреждение "Томский национальный исследовательский медицинский центр" Российской академии наук ("Томский НИМЦ") Способ диагностики рака ободочной кишки

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4925649A (en) 1987-06-12 1990-05-15 The University Of Michigan Radioiodinated diacylglycerol analogues and methods of use
US5347030A (en) 1987-10-23 1994-09-13 The Board Of Regents Of The University Of Michigan Radioiodinated phospholipid ether analogues and methods of using same
US5087721A (en) 1987-10-23 1992-02-11 The University Of Michigan Radioiodinated phosphate esters
US4965391A (en) 1987-10-23 1990-10-23 The University Of Michigan Radioiodinated phospholipid ether analogues
US5369097A (en) 1991-04-25 1994-11-29 The University Of British Columbia Phosphonates as anti-cancer agents
US6255519B1 (en) * 1996-12-04 2001-07-03 Regents Of The University Of Michigan Radioiodinated phospholipid ether analogs and methods of using the same
MXPA06009681A (es) * 2004-03-02 2007-03-15 Cellectar Llc Analogos de fosfolipido para el diagnostico y tratamiento del cancer.
KR20080005178A (ko) * 2004-12-20 2008-01-10 셀렉타, 엘엘씨 암 검출 및 치료용 인지질 에테르 동족체
CN100415584C (zh) * 2005-02-04 2008-09-03 比亚迪股份有限公司 机动车制动防抱死的控制系统和方法

Also Published As

Publication number Publication date
AU2005269861A2 (en) 2006-02-09
US7700075B2 (en) 2010-04-20
US20070098633A2 (en) 2007-05-03
WO2006014589A2 (en) 2006-02-09
JP2008508909A (ja) 2008-03-27
MX2007000207A (es) 2007-03-30
CA2572398A1 (en) 2006-02-09
IL180363A0 (en) 2007-06-03
US20060013767A1 (en) 2006-01-19
WO2006014589A3 (en) 2006-04-20
ZA200700015B (en) 2008-09-25
BRPI0511445A (pt) 2007-12-26
KR20070054630A (ko) 2007-05-29
NZ552914A (en) 2009-12-24
CN101001647A (zh) 2007-07-18
EP1773408A2 (en) 2007-04-18
AU2005269861A1 (en) 2006-02-09

Similar Documents

Publication Publication Date Title
NO20070705L (no) Virituell kolonoskopi med rontgenmerkede fosfolipid eter analoger
López et al. Update on primary head and neck mucosal melanoma
Van Nostrand The benefits and risks of I-131 therapy in patients with well-differentiated thyroid cancer
Tham et al. Treatment of nasopharyngeal carcinoma using intensity-modulated radiotherapy—the National Cancer Centre Singapore experience
Manca et al. Sentinel lymph node mapping in breast cancer: a critical reappraisal of the internal mammary chain issue.
CA2961095C (en) Upar targeting peptide for use in perioperative optical imaging of invasive cancer
EA014870B1 (ru) Антитела к белку steap-1 и их применение
Stoeckli et al. Technique for reliable sentinel node biopsy in squamous cell carcinomas of the floor of mouth
Regal et al. Mediastinal ectopic thyroid mass with normal thyroid function and location: Case report
Dong et al. SPECT/NIRF dual modality imaging for detection of intraperitoneal colon tumor with an avidin/biotin pretargeting system
Rasaneh et al. Toxicity of trastuzumab labeled 177Lu on MCF7 and SKBr3 cell lines
Warner et al. Evaluation of chest radiography versus chest computed tomography in screening for pulmonary malignancy in advanced head and neck cancer.
Li et al. Incidence of second primary tumours in patients with squamous cell carcinoma of the tongue
Murakami et al. Prognostic impact of the level of nodal involvement: retrospective analysis of patients with advanced oral squamous cell carcinoma
Ledbetter Thyroid surgery in children
Fakhry et al. Screening for distant metastases before salvage surgery in patients with recurrent head and neck squamous cell carcinoma: a retrospective case series comparing thoraco‐abdominal CT, positron emission tomography and abdominal ultrasound
Cho et al. Management of cervical lymph node metastasis in tonsillar squamous cell carcinoma: Is it necessary to treat node-negative contralateral neck?
Mecklenburg et al. Detection of melanoma antigen-A expression in sputum and bronchial lavage fluid of patients with lung cancer
Rietbergen et al. Hybrid techniques for intraoperative sentinel lymph node imaging: early experiences and future prospects
Lee et al. Managing nasopharyngeal carcinoma with intracavitary brachytherapy: one institution's 45-year experience
Mahoney et al. Evaluation and management of malignant cervical lymphadenopathy with an unknown primary tumor
Schrock et al. Laryngeal pleomorphic rhabdomyosarcoma
Kumar et al. Laryngeal metastases from breast cancer: a rare clinical entity
Siddique et al. A rare case of gingival metastases from papillary thyroid carcinoma
Israel et al. October 17, 2000 8: 30—8: 45: The New Technology of Combined Transmission and Emission F-18 FDG Tomography (FDG-TET) in the Diagnosis and Management of Cancer Patients

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application